Pricing Log in Create free account
Saturday 17 October 2026 Export BSX’s income statement to Excel — free account

Boston Scientific Corporation

BSX Healthcare Medical Devices

Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 7.53%, EPS grew 14.8%, free cash flow grew 13.3% and total debt rose 8.95%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

44.39 0.25 +0.57%
Market cap
$64.0B
P/E
17.9×
Fwd P/E
17.8×
Dividend yield
—
F-score
7/9
Altman Z
5.41
Beneish M
−2.49
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Boston Scientific Corporation (BSX) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Boston Scientific Corporation (BSX) trades at a price to free cash flow of 18.0×. Over the past ten years it has ranged from 16.9× (October 2026) to 7,034× (March 2019); the current reading is higher than 1% of that period. That is below the Medical Devices industry median of 23.7× and below the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 38.6× (22.34%)
FY2024 49.7× 5.96%
FY2023 46.9× (32.31%)
FY2022 69.3× 52.51%
FY2021 45.4× 2.04%
FY2020 44.5× (2.22%)
FY2019 45.5× (99.25%)
FY2018 6,101× 19,397.92%
FY2017 31.3× (12.05%)
FY2016 35.6× (36.14%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 17.3× (35.44%)
Mar 2026 26.8× (30.51%)
Dec 2025 38.6× 2.01%
Sep 2025 37.8× (17.06%)
42 more quarters

Against its own ten years

Low 16.9× High 7,034×
Ten-year median 49.7×
Current reading's percentile 1

Price to free cash flow against peers

Company Price to free cash flow
PHG Koninklijke Philips N.V. compare 13.3×
BSX Boston Scientific Corporation 18.0×
MDT Medtronic PLC compare 19.8×
GEHC GE HealthCare Technologies Inc. compare 20.0×
STE STERIS plc compare 23.2×
ABT Abbott Laboratories compare 23.3×
DXCM DexCom, Inc. compare 23.4×
SYK Stryker Corporation compare 24.0×
EW Edwards Lifesciences Corporation compare 35.6×
Medical Devices industry median 23.7×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on BSX